Tempest Therapeutics, Inc. SEC filings TPST
Tempest Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 1, 2013. Its latest annual report, Form ARS, was filed on Nov 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 8, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 13, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 12, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 15, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 9, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 9, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 3, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 2, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 3, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 9, 2017 | Mar 31, 2017 |
| 10-Q | Quarterly report | Nov 3, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 4, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | May 5, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Nov 5, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 10, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | May 11, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Nov 10, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 7, 2014 | Jun 30, 2014 |
| 10-Q | Quarterly report | May 8, 2014 | Mar 31, 2014 |
| 10-Q | Quarterly report | Nov 13, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Aug 13, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | May 15, 2013 | Mar 31, 2013 |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TPST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1544227
- Former names
- Millendo Therapeutics, Inc. (until Jul 1, 2021); OvaScience, Inc. (until Dec 6, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.